| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 2 | |
| #2 | New Zealand | 2 | |
| #3 | Brazil | 1 | |
| #4 | China | 1 | |
| #5 | EPO (European Patent Office) | 1 | |
| #6 | Norway | 1 | |
| #7 | United States | 1 | |
| #8 | WIPO (World Intellectual Property Organization) | 1 | |
| #9 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Measuring microorganism processes | |
| #3 | Therapeutic chemical compounds | |
| #4 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wooster Richard | 10 |
| #2 | Marshall Chris | 6 |
| #3 | Futreal Andy | 6 |
| #4 | Stratton Mike | 6 |
| #5 | Stratton Michael | 4 |
| #6 | Marais Richard Malcolm | 4 |
| #7 | Futreal Andrew | 4 |
| #8 | Malcolm Richard | 1 |
| #9 | Richard Stratton Michael Futre | 1 |
| #10 | Marais Richard M | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CA2575462A1 | Mutations in erb2 associated with cancerous phenotypes | |
| CN101023097A | Mutations in erb2 associated with cancerous phenotypes | |
| CA2471114A1 | Mutant b-raf polypeptide and a use thereof in the diagnosis of cancer |